Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 01 Mar 2023
Ophthalmological Clinical Trials Still Show Sociodemographic Disparities.
Read Full NewsForget salary. The cities winning the physician satisfaction race are playing a completely different game.
The prevalence of type 2 diabetes is rising among US youth, and if we don’t address the real causes, we really will see a potentially unstoppable surge.
Current evidence supports the use of this botanical agent to promote skin health, but more research is needed to ascertain more varied and curative applications for this popular natural product.
CRISPR cures for sickle cell disease, gene therapy for hemophilia A, and expanding CAR T cell uses point to a new era of potentially curative, personalized treatments.
Dr Teresa Amaral reviews new uveal melanoma guidelines, focusing on AJCC 8th Edition staging, the Liverpool prognostic tool, and the essential role of BAP1 and PRAME expression.
The Red Cross on Saturday paid tribute to three volunteers who are believed to have died after contracting Ebola while handling bodies.
Americans coming back from the Democratic Republic of the Congo, Uganda or South Sudan now have a second entry point for returning to the United States, with the CDC on...
1.
Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards
2.
Global warming could be driving up women's cancer risk, find researchers
3.
Kate Middleton Gives Cancer Update
4.
In Advanced Myxoid Liposarcoma, Is Trabectedin Winning?
5.
In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.
1.
Organoids & Single-Cell Tools: Breakthroughs in Colorectal Cancer Research
2.
Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies
3.
What Is A High MCV Level? Causes, Symptoms, And Treatment Options
4.
Breaking Barriers in Cancer Treatment: The Role of Innovative Oncology Drugs
5.
HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Navigating the Complexities of Ph Negative ALL - Part IV
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge